leuprolide and Leukemia

leuprolide has been researched along with Leukemia* in 4 studies

Trials

2 trial(s) available for leuprolide and Leukemia

Article	Year
Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease. Blood, 1999, May-01, Volume: 93, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Hormone Replacement Therapy; Humans; Leukemia; Leuprolide; Lymphoma; Middle Aged; Premenopause; Risk Factors; Uterine Hemorrhage; Vascular Diseases	1999
Treatment and prophylaxis of hypermenorrhea with leuprorelin in premenopausal women affected by acute leukemia at diagnosis. American journal of hematology, 1996, Volume: 51, Issue:3 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Hormonal; Female; Humans; Leukemia; Leuprolide; Menorrhagia	1996

Article

Year

Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease.

Blood, 1999, May-01, Volume: 93, Issue:9

Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Hormone Replacement Therapy; Humans; Leukemia; Leuprolide; Lymphoma; Middle Aged; Premenopause; Risk Factors; Uterine Hemorrhage; Vascular Diseases

1999

Treatment and prophylaxis of hypermenorrhea with leuprorelin in premenopausal women affected by acute leukemia at diagnosis.

American journal of hematology, 1996, Volume: 51, Issue:3

Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Hormonal; Female; Humans; Leukemia; Leuprolide; Menorrhagia

1996

Other Studies

2 other study(ies) available for leuprolide and Leukemia

Article	Year
Leuprorelin acetate for female patients with newly diagnosed acute leukemia receiving chemotherapy. International journal of hematology, 2007, Volume: 86, Issue:2 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Hormonal; Drug Evaluation; Female; Humans; Leukemia; Leuprolide; Menstruation; Ovulation; Primary Ovarian Insufficiency; Retrospective Studies	2007
Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate. The Journal of reproductive medicine, 1997, Volume: 42, Issue:9 To evaluate, in a pilot study, the use and efficacy of a gonadotropin-releasing hormone (GnRH)-agonist in inducing amenorrhea in women undergoing BMT.. We evaluated the use of the GnRH agonist leuprolide acetate (LA) for the induction of amenorrhea in 10 postmenarcheal women prior to BMT. If there was a contraindication to the use of the intramuscular (i.m.) formulation of LA, the subcutaneous (s.c.) formulation was given as a daily intravenous (i.v.) bolus. Once the subject's platelet count was > 50,000/microL, the LA was discontinued. Menstrual bleeding, time from initiation of therapy to amenorrhea, and liver function test results were monitored.. All subjects had induction of amenorrhea with the use of LA except for one subject with a large, myomatous uterus, who experienced light spotting. One subject who was thrombocytopenic at the prescribed time of the second dosage of i.m. LA received i.v. LA with documentation of continued pituitary/gonadal suppression. No adverse effects were determined to be directly related to either the i.m. or i.v. LA.. LA is an option for the induction of amenorrhea in postmenarcheal women undergoing BMT. In thrombocytopenic subjects, administration of the s.c. formulation of LA by an i.v. route served as an alternative to i.m. injection and was documented to maintain gonadotropin suppression. Topics: Adolescent; Adult; Amenorrhea; Bone Marrow Transplantation; Contraindications; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Leukemia; Leuprolide; Lymphoma; Pilot Projects; Platelet Count; Uterine Hemorrhage	1997

Article

Year

Leuprorelin acetate for female patients with newly diagnosed acute leukemia receiving chemotherapy.

International journal of hematology, 2007, Volume: 86, Issue:2

Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Hormonal; Drug Evaluation; Female; Humans; Leukemia; Leuprolide; Menstruation; Ovulation; Primary Ovarian Insufficiency; Retrospective Studies

2007

Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate.

The Journal of reproductive medicine, 1997, Volume: 42, Issue:9

To evaluate, in a pilot study, the use and efficacy of a gonadotropin-releasing hormone (GnRH)-agonist in inducing amenorrhea in women undergoing BMT.. We evaluated the use of the GnRH agonist leuprolide acetate (LA) for the induction of amenorrhea in 10 postmenarcheal women prior to BMT. If there was a contraindication to the use of the intramuscular (i.m.) formulation of LA, the subcutaneous (s.c.) formulation was given as a daily intravenous (i.v.) bolus. Once the subject's platelet count was > 50,000/microL, the LA was discontinued. Menstrual bleeding, time from initiation of therapy to amenorrhea, and liver function test results were monitored.. All subjects had induction of amenorrhea with the use of LA except for one subject with a large, myomatous uterus, who experienced light spotting. One subject who was thrombocytopenic at the prescribed time of the second dosage of i.m. LA received i.v. LA with documentation of continued pituitary/gonadal suppression. No adverse effects were determined to be directly related to either the i.m. or i.v. LA.. LA is an option for the induction of amenorrhea in postmenarcheal women undergoing BMT. In thrombocytopenic subjects, administration of the s.c. formulation of LA by an i.v. route served as an alternative to i.m. injection and was documented to maintain gonadotropin suppression.

Topics: Adolescent; Adult; Amenorrhea; Bone Marrow Transplantation; Contraindications; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Leukemia; Leuprolide; Lymphoma; Pilot Projects; Platelet Count; Uterine Hemorrhage

1997